Growth hormone axis overview--somatomedin hypothesis.

Area of Science:

• Endocrinology
• Molecular Biology
• Skeletal Biology

Background:

• Growth hormone (GH) action on cartilage was initially thought to be indirect.
• A serum factor was proposed to mediate GH's effects on cartilage growth.
• Insulin-like growth factor-I (IGF-I) is now recognized as a key mediator.

Purpose of the Study:

• To investigate the role of serum factors in mediating GH action on cartilage.
• To elucidate the direct versus indirect effects of GH on cartilage growth.
• To understand the autocrine-paracrine and endocrine roles of IGF-I in cartilage and systemic regulation.

Main Methods:

• Incubation of hypophysectomized rat costal cartilage with serum and/or GH.
• Measurement of 35S-sulfate uptake as an index of growth stimulation.
• Analysis of IGF-I feedback mechanisms and its role in various physiological and pathological conditions.

Main Results:

• Normal rat serum, but not hypophysectomized rat serum, stimulated 35S-sulfate uptake, indicating a serum mediator.
• GH alone showed minimal direct effect in initial incubations, supporting the mediator hypothesis.
• GH can directly stimulate IGF-I expression in cartilage (autocrine-paracrine) and influences systemic IGF-I levels.

Conclusions:

• IGF-I is a critical mediator of GH action on cartilage growth, acting both systemically and locally.
• Serum IGF-I levels are vital indicators for assessing GH activity, hypersecretion (acromegaly), and growth impairment.
• Obesity and GH receptor status significantly impact IGF-I production and GH secretion, influencing stature.